{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:10Z","timestamp":1787109910247,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4705,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.anpedi.2013.01.022","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T12:07:04Z","timestamp":1363176424000},"page":"208-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluaci\u00f3n de la vacuna pand\u00e9mica antigripal A\/H1N1 adyuvada MF59. Revisi\u00f3n sistem\u00e1tica de la literatura"],"prefix":"10.1016","volume":"79","author":[{"given":"J.","family":"Ruiz-Arag\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Grande Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"M\u00e1rquez-Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Molina Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2013.01.022_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anpedi.2009.09.009","article-title":"Grupo de Trabajo de Pediatr\u00eda Basada en la Evidencia (GT-PBE). Evidencias de la pandemia por virus influenza A (H1N1)","volume":"71","author":"Bu\u00f1uel Alvarez","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MOP.0b013e3283350317","article-title":"Update on the 2009 pandemic influenza A H1N1 in children","volume":"22","author":"Halasa","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0015","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1016\/j.vaccine.2011.08.111","article-title":"Trivalent and quadrivalent MF59(\u00ae)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study","volume":"29","author":"Della Cioppa","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0020","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.anpedi.2009.12.001","article-title":"Recomendaciones sobre el tratamiento de la gripe en pediatr\u00eda (2009-2010)","volume":"72","author":"Mar\u00e8s","year":"2010","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2005.09.017","article-title":"Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence","volume":"24","author":"Jordan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0030","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0035","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","volume":"8","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0045","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1542\/peds.2010-1920","article-title":"Influenza A\/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months","volume":"127","author":"Esposito","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0050","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/INF.0b013e318257644f","article-title":"Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A\/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4161\/hv.7.1.13411","article-title":"Assessment of the safety, tolerability and kinetics of the immune response to A\/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age","volume":"7","author":"Arguedas","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0060","unstructured":"U.S. Food and Drug Administration [Internet]. Centre for Biologics Evaluation and Research. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines [consultado 15 Jun 2012]. Disponible en: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm074786.htm"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0065","unstructured":"Programa de lectura cr\u00edtica CASPe [Internet]. Entendiendo la evidencia sobre la eficacia cl\u00ednica. 11 preguntas para entender un ensayo cl\u00ednico [consultado 12 Jun 2012]. Disponible en: http:\/\/www.redcaspe.org\/herramientas\/lectura\/11ensayo.pdf"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.vaccine.2012.06.030","article-title":"An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria(\u00ae) in a province of Emilia-Romagna region, Italy - Part one","volume":"31","author":"Candela","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0075","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1016\/j.vaccine.2010.06.060","article-title":"Safety and immunogenicity of an inactivated split-virus influenza A\/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial","volume":"28","author":"Oh","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"375","author":"Liang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0085","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0090","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1464-5491.2011.03449.x","article-title":"Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus","volume":"28","author":"Zuccotti","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0095","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/gfq657","volume":"26","author":"Esposito","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0100","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2012.03.053","article-title":"Assessment of the immunogenicity and safety of varying doses of an MF59(\u00ae)-adjuvanted cell culture-derived A\/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects","volume":"30","author":"Fukase","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0105","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/INF.0b013e31824b9545","article-title":"Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A\/H1N1 influenza vaccine in children 3 to < 9 years of age","volume":"31","author":"Nassim","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12325-010-0043-4","article-title":"Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A\/H1N1v vaccine in Japanese children","volume":"27","author":"Yasuda","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0115","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/CVI.05111-11","article-title":"Immunogenicity and safety of the influenza A\/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus non-adjuvanted vaccine","volume":"18","author":"Cheong","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1248\/yakushi.131.1733","article-title":"MF59 Adjunvanted seasonal and pandemic influenza vaccines","volume":"131","author":"Tsai","year":"2011","journal-title":"Yakugazu Zasshi"},{"key":"10.1016\/j.anpedi.2013.01.022_bib0125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/hv.19917","article-title":"Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses","volume":"8","author":"Manzoli","year":"2012","journal-title":"Hum Vaccin Immunother"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:35:28Z","timestamp":1787106928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403313000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1695403313000623"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.01.022","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n de la vacuna pand\u00e9mica antigripal A\/H1N1 adyuvada MF59. Revisi\u00f3n sistem\u00e1tica de la literatura","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}